HK1210600A1 - 含有 特異性表位和/或血管生成素- 特異性表位的 疫苗 - Google Patents

含有 特異性表位和/或血管生成素- 特異性表位的 疫苗

Info

Publication number
HK1210600A1
HK1210600A1 HK15111396.0A HK15111396A HK1210600A1 HK 1210600 A1 HK1210600 A1 HK 1210600A1 HK 15111396 A HK15111396 A HK 15111396A HK 1210600 A1 HK1210600 A1 HK 1210600A1
Authority
HK
Hong Kong
Prior art keywords
vegf
specific epitope
dna
angiopoietin
vaccine containing
Prior art date
Application number
HK15111396.0A
Other languages
English (en)
Inventor
中神启德
久德真梨子
森下龍
富岡英樹
Original Assignee
Univ Osaka
Anges Mg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka, Anges Mg Inc filed Critical Univ Osaka
Publication of HK1210600A1 publication Critical patent/HK1210600A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00113—Growth factors
    • A61K39/001135—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10141—Use of virus, viral particle or viral elements as a vector
    • C12N2730/10143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15111396.0A 2012-08-31 2015-11-19 含有 特異性表位和/或血管生成素- 特異性表位的 疫苗 HK1210600A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012191717 2012-08-31
PCT/JP2013/073045 WO2014034735A1 (ja) 2012-08-31 2013-08-28 Ｖｅｇｆ及び／又はアンギオポエチン－２の特異的エピトープを含むｄｎａワクチン

Publications (1)

Publication Number Publication Date
HK1210600A1 true HK1210600A1 (zh) 2016-04-29

Family

ID=50183541

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15111302.3A HK1210433A1 (zh) 2012-08-31 2015-11-17 含有 特異性表位和/或血管生成素- 特異性表位的 疫苗
HK15111396.0A HK1210600A1 (zh) 2012-08-31 2015-11-19 含有 特異性表位和/或血管生成素- 特異性表位的 疫苗

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15111302.3A HK1210433A1 (zh) 2012-08-31 2015-11-17 含有 特異性表位和/或血管生成素- 特異性表位的 疫苗

Country Status (8)

Country Link
US (1) US10543261B2 (zh)
EP (1) EP2891497B1 (zh)
JP (2) JP6422022B2 (zh)
KR (1) KR102205077B1 (zh)
CN (1) CN104768575B (zh)
ES (1) ES2817925T3 (zh)
HK (2) HK1210433A1 (zh)
WO (1) WO2014034735A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107530408A (zh) 2014-11-20 2018-01-02 安琪士摩奇株式会社 Dna‑肽组合疫苗
EP4205762A1 (en) 2020-10-02 2023-07-05 Osaka University Improved dna vaccine for sars-cov-2
AU2022208435A1 (en) 2021-01-18 2023-08-10 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1406629A (en) 1917-07-03 1922-02-14 John S Erickson Combination lock
NZ235315A (en) 1989-09-19 1991-09-25 Wellcome Found Chimaeric hepadnavirus core antigen proteins and their construction
DK0584348T3 (da) 1992-03-11 2005-09-19 Powderject Vaccines Inc Genetisk vaccine mod immundefektvirusser
BR0109919A (pt) * 2000-04-07 2003-03-11 Univ Leeds Innovations Ltd Proteìna, partìcula, molécula de ácido nucleico, célula hospedeira, processo para produzir uma proteìna, composição farmacêutica, uso de uma proteìna, e, método de vacinação profilática ou terapêutica de um indivìduo
ES2260235T3 (es) 2000-06-22 2006-11-01 Ucb Pharma Limited Modificacion del antigeno "core" de la hepatitis b.
US20030138769A1 (en) 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
CN1298385C (zh) 2001-08-13 2007-02-07 四川大学华西医院 异种血管内皮细胞生长因子疫苗及其制备方法
EP1432443B1 (en) 2001-10-05 2009-01-21 Cytos Biotechnology AG Angiotensin peptide-carrier conjugates and uses thereof
US7094410B2 (en) 2002-03-02 2006-08-22 The Scripps Research Institute DNA vaccine against proliferating endothelial cells and methods of use thereof
CU23178A1 (es) * 2002-04-15 2006-09-22 Ct Ingenieria Genetica Biotech INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
GB0213878D0 (en) * 2002-06-17 2002-07-31 Protherics Plc Use
CN105085678B (zh) 2004-12-21 2019-05-07 阿斯利康公司 血管生成素-2的抗体及其应用
JP5425180B2 (ja) 2008-03-27 2014-02-26 ザイモジェネティクス， インコーポレイテッド ＰＤＧＦＲβおよびＶＥＧＦ−Ａを阻害するための組成物および方法
US8268314B2 (en) * 2008-10-08 2012-09-18 Hoffmann-La Roche Inc. Bispecific anti-VEGF/anti-ANG-2 antibodies
JO3182B1 (ar) 2009-07-29 2018-03-08 Regeneron Pharma مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
TWI426920B (zh) * 2010-03-26 2014-02-21 Hoffmann La Roche 雙專一性、雙價抗－ｖｅｇｆ／抗－ａｎｇ－２抗體
US9113492B2 (en) * 2011-11-07 2015-08-18 Qualcomm Incorporated Method and apparatus for transmit priority determination within a link
JP3228737U (ja) 2020-07-08 2020-11-12 正伸 原田 面マスクホルダー

Also Published As

Publication number Publication date
EP2891497A1 (en) 2015-07-08
US10543261B2 (en) 2020-01-28
JPWO2014034735A1 (ja) 2016-08-08
ES2817925T3 (es) 2021-04-08
KR102205077B1 (ko) 2021-01-20
CN104768575B (zh) 2017-09-08
EP2891497A4 (en) 2016-05-04
HK1210433A1 (zh) 2016-04-22
KR20150070116A (ko) 2015-06-24
US20150202271A1 (en) 2015-07-23
CN104768575A (zh) 2015-07-08
JP6422022B2 (ja) 2018-11-14
JP2018138573A (ja) 2018-09-06
EP2891497B1 (en) 2020-07-01
WO2014034735A1 (ja) 2014-03-06

Similar Documents

Publication Publication Date Title
HK1207967A1 (zh) 疫苗
HK1254894A1 (zh) 自動駕駛儀及其方法
SG11201501837TA (en) Micro-fluidic device and uses thereof
AU350839S (en) Carafe and stopper therefore
EP2877205A4 (en) MULTIMERIC FUSION PROTEIN VACCINE AND IMMUNOTHERAPEUTIC PRODUCT
EP2856954A4 (en) DISPOSABLE BESCHNEIDUNGSANASTOMAT
EP2876161A4 (en) VACCINE
GB201223386D0 (en) Vaccine
EP2902488A4 (en) MODIFIED DNA POLYMERASE
HK1245104A1 (zh) Dna疫苗
HK1211839A1 (zh) 含有肺炎球菌表面蛋白 的肺炎球菌疫苗
EP3685855C0 (en) HUMAN ANTI-VEGFR-2/KDR ANTIBODIES
IL239152A0 (en) Biological mixture inactivated from viruses
GB2517626B (en) Heating vessel
EP2844772A4 (en) DNA SEQUENCING
IL236690A0 (en) ube2t peptides and components containing them
HK1210600A1 (zh) 含有 特異性表位和/或血管生成素- 特異性表位的 疫苗
EP2844775A4 (en) DNA SEQUENCING
TWM433206U (en) Safety syringe
EP2844774A4 (en) DNA SEQUENCING
GB201202090D0 (en) Vaccine
DK2846829T3 (en) Vaccine combinations
GB201213521D0 (en) Single use syringe
GB201213522D0 (en) Single use syringe
GB201217321D0 (en) Vaccine